WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell Wearable Pain Relief Technology™ will be featured at the Combined Sections Meeting of the American Physical Therapy Association in Anaheim, CA from February 17-20th.
"Physical therapists are seeing patients who need or want to increase their level of physical activity. Moreover, chronic pain may limit their interest in or ability to participate in therapy," said Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix. "Quell can provide pain relief and help patients be more active during the day. We look forward to introducing more physical therapists to Quell technology at the Combined Sections Meeting.”
Quell utilizes NeuroMetrix's patented neurostimulation technology to provide widespread relief from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell includes a smartphone app that tracks and personalizes their pain therapy. It is available for purchase at QuellRelief.com, selected retailers and healthcare professionals.
About the American Physical Therapy Association
The American Physical Therapy Association (APTA) is an individual membership professional organization representing more than 93,000 member physical therapists (PTs), physical therapist assistants (PTAs), and students of physical therapy. APTA seeks to improve the health and quality of life of individuals in society by advancing physical therapist practice, education, and research, and by increasing the awareness and understanding of physical therapy's role in the nation's health care system. For more information, please visit www.apta.org.
NeuroMetrix is an innovative healthcare company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.